Smith & Nephew plc (SNN)

Market Cap	13.17B
Revenue (ttm)	5.81B
Net Income (ttm)	412.00M
Shares Out	873.49M
EPS (ttm)	0.47
PE Ratio	31.96
Forward PE	15.01
Dividend	$0.72 (2.46%)
Ex-Dividend Date	Mar 28, 2025

Volume	1,873,872
Open	29.95
Previous Close	30.04
Day's Range	29.29 - 29.96
52-Week Range	23.69 - 31.72
Beta	0.63
Analysts	Hold
Price Target	27.50 (-6.24%)
Earnings Date	Jul 31, 2025

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 16, 1999
• Employees: 18,060
• Stock Exchange: NYSE
• Ticker Symbol: SNN
• Website: https://www.smith-nephew.com

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Analyst Summary

According to 3 analysts, the average rating for SNN stock is "Hold." The 12-month stock price target is $27.5, which is a decrease of -6.24% from the latest price.

Price Target

$27.5

(-6.24% downside)

Analyst Consensus: Hold